The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1189
ISSUE1189
August 16, 2004
Telithromycin (Ketek) for Respiratory Infections--Correction
Med Lett Drugs Ther. 2004 Aug 16;46(1189):66-8
Disclosures
Objective(s)
SUMMARY: Correction: In the table on page 66, the daily dosage of erythromycin should be 250-500 mg qid (not bid). Also, in the Canadian edition, the cost of telithromycin (Ketek) should be $65.52 (not $32.76).
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article